During the past decade, Wright Patterson Medical Center conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 71 clinical trials were completed, i.e. on average, 186.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 35 clinical trials were completed. i.e. 318.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wright Patterson Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 44 trials, followed by "Alliance for Clinical Trials in Oncology" with 32 trials sponsored, "SWOG Cancer Research Network" with 28 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "NSABP Foundation Inc" with 6 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wright Patterson Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 86 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Wright Patterson Medical Center" are "Breast Cancer" (22 trials), "Lung Cancer" (11 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (7 trials), "Colorectal Cancer" (6 trials) and "Pain" (6 trials). Many other conditions were trialed in "Wright Patterson Medical Center" in a lesser frequency.

Most popular intervention types in "Wright Patterson Medical Center" are "Drug" (113 trials), "Other" (80 trials), "Biological" (46 trials), "Procedure" (22 trials) and "Radiation" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (36 trials), "Quality-of-Life Assessment" (26 trials), "Paclitaxel" (19 trials), "placebo" (19 trials) and "Carboplatin" (15 trials). Other intervention names were less common.

The vast majority of trials in "Wright Patterson Medical Center" are 93 trials for "All" genders, 37 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Wright Patterson Medical Center". undefined are not yet recruiting, 11 are recruiting, 46 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 67 completed trials in Wright Patterson Medical Center, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Wright Patterson Medical Center, 2 "Phase 1" clinical trials were conducted, 41 "Phase 2" clinical trials and 92 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".